Results 51 to 60 of about 3,391,346 (320)

The influence of government ideology on monetary policy: New cross‐country evidence based on dynamic heterogeneous panels

open access: yesEconomics & Politics, 2019
Using data of 23 OECD countries over the 1980–2005 period, we examine whether government ideology affects monetary policy, conditional on central bank independence.
Federico M. Giesenow, Jakob Haan
semanticscholar   +1 more source

Driving Forces of the Consumer Price Index During the Crises in the Eurozone: Heterogeneous Panel Approach

open access: yesEconomies
This paper examines key driving forces of inflationary pressures, taking into account supply and demand side determinants and actions of policy makers, during the pandemic and geopolitical crises in the Eurozone.
Jovica Pejčić   +2 more
doaj   +1 more source

Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers

open access: yesVirology Journal, 2021
Background Hepatitis B virus (HBV) serum markers during typical acute self-limited infection are usually depicted as a composite of traditional HBV markers.
Mary C. Kuhns   +4 more
doaj   +1 more source

A Monte Carlo study on the size and power of panel unit root tests: Limitations in small data sets

open access: yesCroatian Operational Research Review, 2023
The aim of this paper is to explore the properties of various panel unit root tests in terms of their power and size regarding different panel data structures, with a special focus on small data samples.
Ivana Mravak
doaj   +1 more source

A NEW PANEL DATA TREATMENT FOR HETEROGENEITY IN TIME TRENDS [PDF]

open access: yesEconometric Theory, 2012
This paper introduces a new estimation method for arbitrary temporal heterogeneity in panel data models. The paper provides a semiparametric method for estimating general patterns of cross-sectional specific time trends. The methods proposed in the paper are related to principal component analysis and estimate the time-varying trend effects using a ...
Kneip, Alois   +2 more
openaire   +2 more sources

Multiplex IgE peanut panels: a critical appraisal of assay designs and the good, the bad, and the ugly features of the applied allergen components

open access: yesFrontiers in Allergy
BackgroundMultiplex allergy assays are currently well-established in allergy diagnostics. However, the different assays in terms of designs and performance are also claimed to be heterogeneous as no agreed standards and requirements are available ...
D. de Boer   +4 more
doaj   +1 more source

Polymyositis Presenting With Nontraumatic Rhabdomyolysis and Dysphagia: A Case Report

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Idiopathic inflammatory myopathies (IIMs) are a rare, heterogeneous group of diseases with a characteristic clinical presentation consisting of muscle inflammation and weakness.
Jonathan Aldrete MD   +3 more
doaj   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Testing for Granger causality in heterogeneous panels with cross-sectional dependence

open access: yesEmpirical Economics
This paper proposes a panel Granger causality approach for heterogeneous panels with cross-sectional dependence. We define a panel VAR model with unobserved common factors and apply the PANIC procedure to obtain the de-factored data. We then estimate the
Ş. Nazlıoğlu, Çağın Karul
semanticscholar   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy